230 related articles for article (PubMed ID: 11923810)
21. Effects of long-term hormone replacement therapy on QT and corrected QT dispersion during resting and peak exercise electrocardiography in post-menopausal women.
Altunkeser BB; Ozdemir K; Içli A; Celik C; Akyürek C; Gök H
Jpn Heart J; 2002 Jan; 43(1):1-7. PubMed ID: 12041885
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
Ryan AS; Nicklas BJ; Berman DM
Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
[TBL] [Abstract][Full Text] [Related]
23. Effects of estrogen and opioid blockade on blood pressure reactivity to stress in postmenopausal women.
Allen AJ; McCubbin JA; Loveless JP; Helfer SG
J Behav Med; 2014 Feb; 37(1):94-101. PubMed ID: 23135529
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
25. Absence of effects of short-term estrogen replacement therapy on resting and exertional QT and QTc dispersion in postmenopausal women with coronary artery disease.
Sbarouni E; Zarvalis E; Kyriakides ZS; Kremastinos DT
Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2392-5. PubMed ID: 9825354
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation.
Christ M; Seyffart K; Tillmann HC; Wehling M
Menopause; 2002; 9(2):127-36. PubMed ID: 11875332
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy and the risk of subarachnoid hemorrhage in postmenopausal women.
Qureshi AI; Malik AA; Saeed O; Defillo A; Sherr GT; Suri MF
J Neurosurg; 2016 Jan; 124(1):45-50. PubMed ID: 26162033
[TBL] [Abstract][Full Text] [Related]
28. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).
Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK
Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228
[TBL] [Abstract][Full Text] [Related]
29. The impact of coronary heart disease in determining use of hormone replacement therapy in a general practice population.
Chin BS; Futaba K; Jethwa A; Lip GY
Int J Clin Pract; 2001 Oct; 55(8):515-8. PubMed ID: 11695070
[TBL] [Abstract][Full Text] [Related]
30. Fatty acid composition of serum phospholipid of premenopausal women and postmenopausal women receiving and not receiving hormone replacement therapy.
Stark KD; Park EJ; Holub BJ
Menopause; 2003; 10(5):448-55. PubMed ID: 14501607
[TBL] [Abstract][Full Text] [Related]
31. Effect of exogenous melatonin on vascular reactivity and nitric oxide in postmenopausal women: role of hormone replacement therapy.
Cagnacci A; Arangino S; Angiolucci M; Melis GB; Facchinetti F; Malmusi S; Volpe A
Clin Endocrinol (Oxf); 2001 Feb; 54(2):261-6. PubMed ID: 11207642
[TBL] [Abstract][Full Text] [Related]
32. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
Vural P; Akgul C; Canbaz M
Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy in clinical cardiology.
Bittner V
Cardiol Rev; 2000; 8(1):57-64. PubMed ID: 11174874
[TBL] [Abstract][Full Text] [Related]
34. Hormone replacement therapy in postmenopausal women with specific risk factors for coronary artery disease.
van der Mooren MJ; Mijatovic V; van Baal WM; Stehouwer CD
Maturitas; 1998 Sep; 30(1):27-36. PubMed ID: 9819780
[TBL] [Abstract][Full Text] [Related]
35. Long-term estrogen replacement therapy is associated with improved exercise capacity in postmenopausal women without known coronary artery disease.
Redberg RF; Nishino M; McElhinney DB; Dae MW; Botvinick EH
Am Heart J; 2000 Apr; 139(4):739-44. PubMed ID: 10740161
[TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of exogenous estrogen versus a estrogen-progesterone combination on auditory evoked potentials in menopausal women.
Khaliq F; Tandon OP; Goel N
Indian J Physiol Pharmacol; 2005; 49(3):345-52. PubMed ID: 16440855
[TBL] [Abstract][Full Text] [Related]
38. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension.
Szekacs B; Vajo Z; Acs N; Hada P; Csuzi L; Bezeredi J; Magyar Z; Brinton EA
Menopause; 2000; 7(1):31-5. PubMed ID: 10646701
[TBL] [Abstract][Full Text] [Related]
39. [Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study].
Kuttenn F; Gerson M; de Lignères B
Presse Med; 2002 Mar; 31(10):468-75. PubMed ID: 11933751
[TBL] [Abstract][Full Text] [Related]
40. Effect of different hormone replacement therapy regimens on circadian blood pressure profile and active renin in postmenopausal women.
Zacharieva S; Kirilov G; Kalinov K; Shigarminova R; Nachev E; Orbetzova M; Atanassova I
Gynecol Endocrinol; 2002 Dec; 16(6):461-7. PubMed ID: 12626033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
